- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Therapeutic Choice and Outcomes at the Physician Level
Anupam Jena, MD, PhD, Assistant Professor of Healthcare Policy, Harvard Medical School, presented research on how therapeutic choice and patient outcomes vary at the physician level.
Anupam Jena, MD, PhD, Assistant Professor of Healthcare Policy, Harvard Medical School, presented research on how therapeutic choice and patient outcomes vary at the physician level. Dr. Jena said that improving US healthcare will rely on better measuring and learning how to shape physician behavior. Throughout this segment, Dr. Jena presents a study that aimed to determine what makes sense for a physician-based measure of performance in diabetes care. He said that the goal was to:
- To propose a measure to study physician level performance in diabetes care.
- To study how the measure varied across physicians.
- To identify high and low performing physicians and see how they differ.
- How many adverse complications related to diabetes be avoided.
Exploring Pharmaceutical Innovations, Trust, and Access With CVS Health's CMO
July 11th 2024On this episode of Managed Care Cast, we're talking with the chief medical officer of CVS Health about recent pharmaceutical innovations, patient-provider relationships, and strategies to reduce drug costs.
Listen
How Can Employers Leverage the DPP to Improve Diabetes Rates?
February 15th 2022On this episode of Managed Care Cast, Jill Hutt, vice president of member services at the Greater Philadelphia Business Coalition on Health, explains the Coalition’s efforts to reduce diabetes rates through the Diabetes Prevention Program (DPP).
Listen
FTC Takes Legal Action Against 3 Largest PBMs Over Insulin Costs
September 20th 2024The Federal Trade Commission (FTC) has filed a legal complaint accusing the 3 largest pharmacy benefit managers (PBMs) in the US—Caremark, Express Scripts, and Optum Rx—of inflating insulin costs for patients, prompting renewed calls for PBM reform.
Read More
Antihyperglycemic Treatment Patterns for Chronic Kidney Disease and Type 2 Diabetes
September 5th 2024This study characterized antihyperglycemic medication use after chronic kidney disease onset among patients with type 2 diabetes to uncover potential unmet needs in clinical practice.
Read More
